Home > Insider Trading > Filing (0000914190-12-000244)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Nile Therapeutics Inc.	NLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221355	A Joshua Kazam	C/O Two River Group Holdings, Llc 689 Fifth Avenue, 12Th Floor New York NY 10022	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-30	125,000	$0.00	1,453,228	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Acquisiton	2012-03-30	93,750	$0.00	93,750	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
93,750			No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	613,841	Indirect	By Kazam Family Trust
Common Stock	165,530	Indirect	By Spouse for Minor Child
Common Stock	165,530	Indirect	By Kash Family Foundation

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$4.50		2018-01-25	50,000	50,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.93	2010-01-01	2018-12-22	25,000	25,000	Direct
Common Stock	Stock Option (Right to Buy)	$1.77	2010-07-21	2019-07-21	65,000	65,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.37	2011-07-26	2020-07-26	80,000	80,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.73	2012-05-10	2021-05-10	80,000	80,000	Direct
Common Stock	Warrant (Right to Buy)	$1.25	2009-07-07	2014-07-07	49,407	49,407	Direct
Common Stock	Warrant (Right to Buy)	$1.71	2009-07-07	2014-07-07	49,407	49,407	Direct
Common Stock	Warrant (Right to Buy)	$2.28	2009-07-07	2014-07-07	98,814	98,814	Direct
Common Stock	Warrant (Right to Buy)	$0.94	2010-04-27	2015-04-21	15,000	15,000	Direct
Common Stock	Warrant (Right to Buy)	$1.38	2009-07-15	2019-07-15	31,650	31,650	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-01-25	50,000	50,000	Direct
2018-12-22	25,000	25,000	Direct
2019-07-21	65,000	65,000	Direct
2020-07-26	80,000	80,000	Direct
2021-05-10	80,000	80,000	Direct
2014-07-07	49,407	49,407	Direct
2014-07-07	49,407	49,407	Direct
2014-07-07	98,814	98,814	Direct
2015-04-21	15,000	15,000	Direct
2019-07-15	31,650	31,650	Direct

Footnotes

The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
Held by Reporting Person's spouse as custodian for the benefit of their minor child under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary intrest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
The Reporting Person is the Trustee of the Kash Family Foundation and controls the right to vote and dispose of the shares held by the Trust. However, the Reporting Person has no pecuniary interest in the shares held by the Foundation.
Fully exercisable.
The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.